darunavir has been researched along with itraconazole in 4 studies
Studies (darunavir) | Trials (darunavir) | Recent Studies (post-2010) (darunavir) | Studies (itraconazole) | Trials (itraconazole) | Recent Studies (post-2010) (itraconazole) |
---|---|---|---|---|---|
1,148 | 224 | 780 | 249 | 4 | 108 |
1,148 | 224 | 780 | 6,440 | 653 | 2,357 |
Protein | Taxonomy | darunavir (IC50) | itraconazole (IC50) |
---|---|---|---|
Tyrosine-protein kinase Fyn | Homo sapiens (human) | 3.89 | |
ATP-dependent translocase ABCB1 | Mus musculus (house mouse) | 0.7 | |
ATP-dependent translocase ABCB1 | Homo sapiens (human) | 1.666 | |
Cytochrome P450 3A4 | Homo sapiens (human) | 0.4256 | |
ATP-dependent translocase ABCB1 | Mus musculus (house mouse) | 0.2 | |
C-X-C chemokine receptor type 1 | Homo sapiens (human) | 2.5676 | |
Cruzipain | Trypanosoma cruzi | 3 | |
Vasopressin V2 receptor | Homo sapiens (human) | 3.476 | |
C-C chemokine receptor type 4 | Homo sapiens (human) | 3.2689 | |
Lanosterol 14-alpha demethylase | Homo sapiens (human) | 3.6 | |
Broad substrate specificity ATP-binding cassette transporter ABCG2 | Homo sapiens (human) | 2 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (50.00) | 24.3611 |
2020's | 2 (50.00) | 2.80 |
Authors | Studies |
---|---|
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Dranchak, PK; Huang, R; Inglese, J; Lamy, L; Oliphant, E; Queme, B; Tao, D; Wang, Y; Xia, M | 1 |
Bonnal, C; Descamps, D; Desselas, E; Giraud, J; Lariven, S; Le Meur, L; LĂȘ, MP; Lillo-Le-Louet, A; Massias, L; Peytavin, G; Sonneville, R; Tantet, C; Yazdanpanah, Y | 1 |
Cai, JP; Chen, C; Gao, N; Hu, GX; Lin, Q; Xie, SL; Xu, RA; Yang, YJ; Zhu, X | 1 |
1 review(s) available for darunavir and itraconazole
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
3 other study(ies) available for darunavir and itraconazole
Article | Year |
---|---|
In vivo quantitative high-throughput screening for drug discovery and comparative toxicology.
Topics: Animals; Caenorhabditis elegans; Drug Discovery; High-Throughput Screening Assays; Humans; Proteomics; Small Molecule Libraries | 2023 |
Serious neuropsychiatric adverse effects related to interaction between itraconazole and darunavir/ritonavir in an HIV-infected patient with cerebral histoplasmosis.
Topics: Anti-HIV Agents; Antifungal Agents; Darunavir; Drug Interactions; Histoplasmosis; HIV Infections; Humans; Itraconazole; Male; Mental Disorders; Middle Aged; Plasma; Ritonavir | 2018 |
Genetic variations of CYP3A4 on the metabolism of itraconazole in vitro.
Topics: Chromatography, Liquid; COVID-19; COVID-19 Drug Treatment; Cytochrome P-450 CYP3A; Darunavir; Drug Interactions; Genetic Variation; Humans; Itraconazole; Lopinavir; Tandem Mass Spectrometry | 2023 |